United States Immunotoxins Market Report 2017

United States Immunotoxins Market Report 2017

1 Immunotoxins Overview

1.1 Product Overview and Scope of Immunotoxins

1.2 Classification of Immunotoxins by Product Category

1.2.1 United States Immunotoxins Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Immunotoxins Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Anthrax Based Toxins

1.2.4 Diphtheria Toxin (DT) & DT Derivatives

1.2.5 Pseudomonas Exotoxin (PE) & PE Derivatives

1.2.6 Ribosome Inactivating Proteins Based Immunotoxins

1.2.7 Ribonucleases based Immunotoxins

1.2.8 Others

1.3 United States Immunotoxins Market by Application/End Users

1.3.1 United States Immunotoxins Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Solid Tumors

1.3.3 Leukemias

1.4 United States Immunotoxins Market by Region

1.4.1 United States Immunotoxins Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Immunotoxins Status and Prospect (2012-2022)

1.4.3 Southwest Immunotoxins Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Immunotoxins Status and Prospect (2012-2022)

1.4.5 New England Immunotoxins Status and Prospect (2012-2022)

1.4.6 The South Immunotoxins Status and Prospect (2012-2022)

1.4.7 The Midwest Immunotoxins Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Immunotoxins (2012-2022)

1.5.1 United States Immunotoxins Sales and Growth Rate (2012-2022)

1.5.2 United States Immunotoxins Revenue and Growth Rate (2012-2022)

2 United States Immunotoxins Market Competition by Players/Suppliers

2.1 United States Immunotoxins Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Immunotoxins Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Immunotoxins Average Price by Players/Suppliers (2012-2017)

2.4 United States Immunotoxins Market Competitive Situation and Trends

2.4.1 United States Immunotoxins Market Concentration Rate

2.4.2 United States Immunotoxins Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Immunotoxins Manufacturing Base Distribution, Sales Area, Product Type

3 United States Immunotoxins Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Immunotoxins Sales and Market Share by Region (2012-2017)

3.2 United States Immunotoxins Revenue and Market Share by Region (2012-2017)

3.3 United States Immunotoxins Price by Region (2012-2017)

4 United States Immunotoxins Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Immunotoxins Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Immunotoxins Revenue and Market Share by Type (2012-2017)

4.3 United States Immunotoxins Price by Type (2012-2017)

4.4 United States Immunotoxins Sales Growth Rate by Type (2012-2017)

5 United States Immunotoxins Sales (Volume) by Application (2012-2017)

5.1 United States Immunotoxins Sales and Market Share by Application (2012-2017)

5.2 United States Immunotoxins Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Immunotoxins Players/Suppliers Profiles and Sales Data

6.1 Biotest

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Immunotoxins Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Biotest Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Celldex Therapeutics

6.2.2 Immunotoxins Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Celldex Therapeutics Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Amgen

6.3.2 Immunotoxins Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Amgen Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Genmab

6.4.2 Immunotoxins Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Genmab Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 AREVA Med

6.5.2 Immunotoxins Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 AREVA Med Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Bayer HealthCare

6.6.2 Immunotoxins Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Bayer HealthCare Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Neurocrine Biosciences

6.7.2 Immunotoxins Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Neurocrine Biosciences Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Research Corporation Technologies

6.8.2 Immunotoxins Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Research Corporation Technologies Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 CuraGen Corporation

6.9.2 Immunotoxins Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 CuraGen Corporation Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Genentech

6.10.2 Immunotoxins Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Genentech Immunotoxins Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Immunotoxins Manufacturing Cost Analysis

7.1 Immunotoxins Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Immunotoxins

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Immunotoxins Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Immunotoxins Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Immunotoxins Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Immunotoxins Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Immunotoxins Sales Volume Forecast by Type (2017-2022)

11.3 United States Immunotoxins Sales Volume Forecast by Application (2017-2022)

11.4 United States Immunotoxins Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Immunotoxins

Figure United States Immunotoxins Market Size (K Pcs) by Type (2012-2022)

Figure United States Immunotoxins Sales Volume Market Share by Type (Product Category) in 2016

Figure Anthrax Based Toxins Product Picture

Figure Diphtheria Toxin (DT) & DT Derivatives Product Picture

Figure Pseudomonas Exotoxin (PE) & PE Derivatives Product Picture

Figure Ribosome Inactivating Proteins Based Immunotoxins Product Picture

Figure Ribonucleases based Immunotoxins Product Picture

Figure Others Product Picture

Figure United States Immunotoxins Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Immunotoxins by Application in 2016

Figure Solid Tumors Examples

Table Key Downstream Customer in Solid Tumors

Figure Leukemias Examples

Table Key Downstream Customer in Leukemias

Figure United States Immunotoxins Market Size (Million USD) by Region (2012-2022)

Figure The West Immunotoxins Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Immunotoxins Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Immunotoxins Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Immunotoxins Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Immunotoxins Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Immunotoxins Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Immunotoxins Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Immunotoxins Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Immunotoxins Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Immunotoxins Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Immunotoxins Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Immunotoxins Sales Share by Players/Suppliers

Figure 2017 United States Immunotoxins Sales Share by Players/Suppliers

Figure United States Immunotoxins Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Immunotoxins Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Immunotoxins Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Immunotoxins Revenue Share by Players/Suppliers

Figure 2017 United States Immunotoxins Revenue Share by Players/Suppliers

Table United States Market Immunotoxins Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Immunotoxins Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Immunotoxins Market Share of Top 3 Players/Suppliers

Figure United States Immunotoxins Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Immunotoxins Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Immunotoxins Product Category

Table United States Immunotoxins Sales (K Pcs) by Region (2012-2017)

Table United States Immunotoxins Sales Share by Region (2012-2017)

Figure United States Immunotoxins Sales Share by Region (2012-2017)

Figure United States Immunotoxins Sales Market Share by Region in 2016

Table United States Immunotoxins Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Immunotoxins Revenue Share by Region (2012-2017)

Figure United States Immunotoxins Revenue Market Share by Region (2012-2017)

Figure United States Immunotoxins Revenue Market Share by Region in 2016

Table United States Immunotoxins Price (USD/Pcs) by Region (2012-2017)

Table United States Immunotoxins Sales (K Pcs) by Type (2012-2017)

Table United States Immunotoxins Sales Share by Type (2012-2017)

Figure United States Immunotoxins Sales Share by Type (2012-2017)

Figure United States Immunotoxins Sales Market Share by Type in 2016

Table United States Immunotoxins Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Immunotoxins Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Immunotoxins by Type (2012-2017)

Figure Revenue Market Share of Immunotoxins by Type in 2016

Table United States Immunotoxins Price (USD/Pcs) by Types (2012-2017)

Figure United States Immunotoxins Sales Growth Rate by Type (2012-2017)

Table United States Immunotoxins Sales (K Pcs) by Application (2012-2017)

Table United States Immunotoxins Sales Market Share by Application (2012-2017)

Figure United States Immunotoxins Sales Market Share by Application (2012-2017)

Figure United States Immunotoxins Sales Market Share by Application in 2016

Table United States Immunotoxins Sales Growth Rate by Application (2012-2017)

Figure United States Immunotoxins Sales Growth Rate by Application (2012-2017)

Table Biotest Basic Information List

Table Biotest Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Biotest Immunotoxins Sales Growth Rate (2012-2017)

Figure Biotest Immunotoxins Sales Market Share in United States (2012-2017)

Figure Biotest Immunotoxins Revenue Market Share in United States (2012-2017)

Table Celldex Therapeutics Basic Information List

Table Celldex Therapeutics Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Celldex Therapeutics Immunotoxins Sales Growth Rate (2012-2017)

Figure Celldex Therapeutics Immunotoxins Sales Market Share in United States (2012-2017)

Figure Celldex Therapeutics Immunotoxins Revenue Market Share in United States (2012-2017)

Table Amgen Basic Information List

Table Amgen Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Amgen Immunotoxins Sales Growth Rate (2012-2017)

Figure Amgen Immunotoxins Sales Market Share in United States (2012-2017)

Figure Amgen Immunotoxins Revenue Market Share in United States (2012-2017)

Table Genmab Basic Information List

Table Genmab Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Genmab Immunotoxins Sales Growth Rate (2012-2017)

Figure Genmab Immunotoxins Sales Market Share in United States (2012-2017)

Figure Genmab Immunotoxins Revenue Market Share in United States (2012-2017)

Table AREVA Med Basic Information List

Table AREVA Med Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure AREVA Med Immunotoxins Sales Growth Rate (2012-2017)

Figure AREVA Med Immunotoxins Sales Market Share in United States (2012-2017)

Figure AREVA Med Immunotoxins Revenue Market Share in United States (2012-2017)

Table Bayer HealthCare Basic Information List

Table Bayer HealthCare Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Bayer HealthCare Immunotoxins Sales Growth Rate (2012-2017)

Figure Bayer HealthCare Immunotoxins Sales Market Share in United States (2012-2017)

Figure Bayer HealthCare Immunotoxins Revenue Market Share in United States (2012-2017)

Table Neurocrine Biosciences Basic Information List

Table Neurocrine Biosciences Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Neurocrine Biosciences Immunotoxins Sales Growth Rate (2012-2017)

Figure Neurocrine Biosciences Immunotoxins Sales Market Share in United States (2012-2017)

Figure Neurocrine Biosciences Immunotoxins Revenue Market Share in United States (2012-2017)

Table Research Corporation Technologies Basic Information List

Table Research Corporation Technologies Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Research Corporation Technologies Immunotoxins Sales Growth Rate (2012-2017)

Figure Research Corporation Technologies Immunotoxins Sales Market Share in United States (2012-2017)

Figure Research Corporation Technologies Immunotoxins Revenue Market Share in United States (2012-2017)

Table CuraGen Corporation Basic Information List

Table CuraGen Corporation Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure CuraGen Corporation Immunotoxins Sales Growth Rate (2012-2017)

Figure CuraGen Corporation Immunotoxins Sales Market Share in United States (2012-2017)

Figure CuraGen Corporation Immunotoxins Revenue Market Share in United States (2012-2017)

Table Genentech Basic Information List

Table Genentech Immunotoxins Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Genentech Immunotoxins Sales Growth Rate (2012-2017)

Figure Genentech Immunotoxins Sales Market Share in United States (2012-2017)

Figure Genentech Immunotoxins Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Immunotoxins

Figure Manufacturing Process Analysis of Immunotoxins

Figure Immunotoxins Industrial Chain Analysis

Table Raw Materials Sources of Immunotoxins Major Players/Suppliers in 2016

Table Major Buyers of Immunotoxins

Table Distributors/Traders List

Figure United States Immunotoxins Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Immunotoxins Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Immunotoxins Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Immunotoxins Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Immunotoxins Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Immunotoxins Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Immunotoxins Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Immunotoxins Sales Volume Share Forecast by Region (2017-2022)

Figure United States Immunotoxins Sales Volume Share Forecast by Region (2017-2022)

Figure United States Immunotoxins Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources